Skip to main content
. 2018 Oct 1;9(12):1603–1613. doi: 10.1111/1759-7714.12868

Figure 1.

Figure 1

(a) Overall and (b) cancer‐specific survival in patients with thymic neuroendocrine tumors (TNETs), thymoma, and thymic carcinoma. CI, confidence interval; HR, hazard ratio. (Inline graphic) TNETs, (Inline graphic) Thymoma and (Inline graphic) Thymic carcinoma